Prospera Financial Services’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-75
Closed -$2K 1077
2022
Q2
$2K Hold
75
﹤0.01% 1543
2022
Q1
$3K Buy
+75
New +$3K ﹤0.01% 2376
2020
Q4
Sell
-361
Closed -$14K 943
2020
Q3
$14K Buy
+361
New +$14K 0.01% 1004